drugset / Trial / NCT01125553
A Comparison Between Two Formulations of NN5401 in Healthy Subjects
RandomizedCrossoverDouble-blindTreatment
Summary
This trial is conducted in the United States of America (USA). The aim of the trial is to compare the exposure of two formulations of insulin degludec/insulin aspart (NN5401) in healthy subjects.
Timeline
- Start
- 2010-05
- Primary completion
- 2010-08
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | insulin degludec/insulin aspart | Unknown | — | Subcutaneous |